Plans call for the pipeline to carry greenhouse gas emissions from more than 50 ethanol plants in Iowa, Minnesota, Nebraska, North Dakota and South Dakota to a spot in North Dakota, where it would ...

Concerns about the Ethanol Blended Petrol (EBP) programme refuse to die down in Andhra Pradesh, with scientists and farmers saying water resources are depleting and emissions from factories are ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic improvement at Week 12 of its phase 2 ulcerative colitis trial. The new duvakitug data also clear up the ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

A new catalyst allows selective production of hydrogen and acetic acid from ethanol, with no direct carbon dioxide emissions. The researchers behind the work believe that the reaction could now ...

Department of Semiconductors, Institute of Physics of the Czech Academy of Sciences, Cukrovarnická 10/112, Prague 6 162 00, Czech Republic Department of Microelectronics, Faculty of Electrical ...

When asked about how the upcoming norms will address different fuel types, particularly ethanol blended fuels (petrol for now), Banerjee highlights, “Higher ethanol blends pose challenges ...

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret antigens that could form the backbone of off-the-shelf immunotherapies ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022, ...